Nu Skin Enterprises (NUS) Slammed as Citron Says China Sales in Jeopardy on Violations

Article Stock Quotes (1) Comments (0)

Nu Skin Enterprises Inc. (NYSE: NUS) has found itself the target of famed short-selling website Citron Research, and investor are already running for the hills.

Citron belieives Nu Skin Enterprises is violating "direct selling" rules in China, "and their entire Chinese business operation could be in jeopardy of seizure and other substantial risks."

"Nu Skin investors are exposed to the massive risk of its China operations coming to an abrupt halt due to violation of the PRC’s and Hong Kong pyramid sales laws. The consequences would be devastating," Citron concludes.

Shares of NUS are down 8.5 percent to $44.70 on the negative mention.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Yahoo! (YHOO) Board Said to Approve $1.1B Tumblr Deal
• Apple (AAPL) Said to Evaluate OLED Screen Sizes for Rumored 'iWatch'
• UPDATE: Student Loan Rates Set for Change; ITT (ESI) & Corinthian (COCO) on Move

Create E-mail Alert Related Categories

Insiders' Blog, Trader Talk

Related Entities

Citron Research

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?